SCHEMBL21479978

SCHEMBL21479978

Cc1ccccc1N(C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38
CHKA P35790 5/20 0.38
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
GSK3B P49841 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20384981 0.87 TSHR (0.41) CHKASLC6A2SLC6A4SIGMAR1
SCHEMBL2198610 0.87 TSHR (0.41) CHKASLC6A2SLC6A4SIGMAR1
Hydrochloric Acid SCHEMBL28328614 0.83 TSHR (0.38) CHKASLC6A2SLC6A4SIGMAR1
SCHEMBL13367414 0.83 TSHR (0.46) ALDH1A1SIGMAR1HSD17B1HSD17B2MAPK13
SCHEMBL20210324 0.82 SMN1; SMN2 (0.37) TAAR1ALDH1A1KDM4ECHKAHSD17B1
SCHEMBL20210349 0.82 POLB (0.35) TAAR1ALDH1A1KDM4ECHKAHSD17B1
SCHEMBL15306327 0.82 ALDH1A1 (0.38) TAAR1ALDH1A1KDM4EUSP2
SCHEMBL19393440 0.82 ALDH1A1 (0.38) TAAR1ALDH1A1KDM4EUSP2
SCHEMBL17368989 0.82 ALDH1A1 (0.38) TAAR1ALDH1A1KDM4EUSP2
SCHEMBL24774796 0.81 CHKA (0.40) TAAR1CHKAGSK3BHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2023-02-21 US disclosed
US-20190315764-A1 BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315764-A1 BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) OCIAD1, OCIAD2, AOC1 TAAR1 420/4885ALDH1A1 99/4885KDM4E 3832/4885
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD1, OCIAD2, AOC1 TAAR1 420/4885ALDH1A1 99/4885KDM4E 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.